Please Wait...

Barbara Clendenen

Main profile

Barbara Clendenen, MBA
Barbara Clendenen, MBA
Director, Business Development, Drug Safety and Regulatory

Barbara Clendenen, MBA, designs Pharmacovigilance and Regulatory solutions that increase compliance and reduce risk for life science organizations. She has over 20 years of experience blending both science and business expertise to assist pharmaceutical, biotech, medical device, and CRO clients in meeting research and post marketing goals. She began her career as a research scientist in Immunology and Oncology.  Since 1998, she has held pivotal roles in business development and sales management within the scientific and clinical research industry for Becton Dickinson, Fisher Scientific, and Bio-Rad. Prior to joining Bioclinica in 2015, she led the Business Development Team at Quorum Review IRB, developed the organization's entry into the hospital and AMC market, and participated in CIRB (Consortium of Independent Review Boards). Barbara graduated from University of Washington with a Bachelor's degree in Microbiology and from Seattle University with a Master's in Business Administration.

Blogs

The electronic common technical document (eCTD) is an interface for the pharmaceutical industry to transfer regulatory information based on the Common Technical Document (CTD) format, which is an agreed common format for applications that will be acceptable in all three ICH-Regions (US, EU & Japan) and other countries.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

[Fun Friday] Now that's using you noodle! Ck this out in @RandDMagazine https://t.co/o5h9O1ScBF
bioclinica (7 hours ago)
FDA, NIH & Industry Advance Templates for Clinical Trial Protocols | RAPS https://t.co/Cqda7fLQZf
bioclinica (Yesterday)
Significant Safety Events Found in a Third of FDA-Approved Drugs, Study Finds | RAPS https://t.co/mAHe42W4or
bioclinica (Yesterday)
FDA Official Highlights Foreign Supply Chain Challenges | RAPS https://t.co/qHDtoRw9MS
bioclinica (Yesterday)
RT @MySCRS: Survey finds 50% of Americans are unaware of #ClinicalTrials, reported by @EdClinical. https://t.co/57x8gtXRT0
bioclinica (Yesterday)
RT @ACROhealth: Recent poll data from @ResearchAmerica, 59% of those polled said their family’s health has been improved by clinical resear…
bioclinica (Yesterday)

Latest Blogs: